An investigation for investors in DURECT Corporation (NASDAQ:DRRX) shares over potential securities laws violations by DURECT was announced and NASDAQ:DRRX stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com

San Diego, CA -- (SBWire) -- 05/15/2013 --An investigation on behalf of investors of DURECT Corporation (NASDAQ:DRRX) shares over potential securities laws violations by DURECT and certain of its directors and officers in connection certain financial statements was announced.

Investors who purchased shares of DURECT Corporation (NASDAQ:DRRX), have certain options and should contact the Shareholders Foundation at mail(at)shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of DURECT Corporation (NASDAQ:DRRX) concerning whether a series of statements by DURECT regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

DURECT Corporation reported that its annual Total Revenue rose from $24.46 million in 2009 to $53.07 million in 2012 and that its Net Loss of $30.29 million in 2009 turned into a Net Income of $16.20 million in 2012.

Then on May 10, 2013, DURECT Corporation announced that Pfizer has provided an update on Remoxy.

Shares of DURECT Corporation declined from $1.64 per share on May 8, 2013, to $0.79 per share on May 10, 2013.

On May 14, 2013, NASDAQ:DRRX shares closed at $1.02 per share.

Those who purchased shares of DURECT Corporation (NASDAQ:DRRX), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Jacob Rosenfeld
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com